General Practice Doctors in Leesburg, FL Accepting Medicare

7 General Practice doctors found. Showing 1 - 7

Dr. Jackeline Lopez, General Practice Medicare: Accepting Medicare Assignments Practice Location: 801 E Dixie Ave Ste 101, Leesburg, FL 34748 Phone: 352-326-4031    Fax: 352-360-0257

Dr. Gilbert Acevedo Acosta, M.D. General Practice Medicare: Medicare Enrolled Practice Location: 801 E Dixie Ave Ste 101, Leesburg, FL 34748 Phone: 352-326-4031    Fax: 352-360-0257

Jose Llamas, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: 601 E Dixie Ave Ste 102, Leesburg, FL 34748 Phone: 352-350-8888    Fax: 352-350-2014

Blandine Pierre, MD General Practice Medicare: Medicare Enrolled Practice Location: 225 N 1st St, Leesburg, FL 34748 Phone: 407-905-8827    Fax: 352-360-2389

Dr. Hamidreza Ebneshahidi, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: 601 E Dixie Ave Ste 102, Leesburg, FL 34748 Phone: 352-350-8888    Fax: 844-388-6186

Omar Jose Vazquez Alicea, MD General Practice Medicare: Medicare Enrolled Practice Location: 225 N 1st St, Leesburg, FL 34748 Phone: 407-905-8827    Fax: 352-360-2389

Dr. Yanira R. Feliciano Montalvo, M.D. General Practice Medicare: Accepting Medicare Assignments Practice Location: 601 E Dixie Ave Ste 102, Leesburg, FL 34748 Phone: 352-350-8888    Fax: 844-388-6186

News Archive

Engineers have found a way to modify a plastic to anchor molecules that promote nerve regeneration, blood vessel growth or other biological processes

In the study led by Dr. Christine Schmidt, the researchers identified a piece of protein from among a billion candidates that could perform the unusual feat of attaching to polypyrrole, a synthetic polymer (plastic) that conducts electricity and has shown promise in biomedical applications.

ATSP-7041 stapled peptide activates p53, suppresses tumor growth in animal models

Aileron Therapeutics, Inc., a clinical stage biopharmaceutical company that is developing first-in-class therapeutics based on its proprietary Stapled Peptide drug platform, announced today the publication of preclinical data on ATSP-7041, a potent and selective stapled peptide re-activator of the wild type p53 tumor suppressor protein.

The LINC complex essential for hearing

In this issue of the Journal of Clinical Investigation, Karen Avraham and colleagues at Tel Aviv University identified a genetic mutation in two families with hereditary high frequency hearing loss. The mutated gene, which has not previously been linked to hearing loss, encodes NESP4, a protein that is expressed in the outer nuclear membrane (ONM) of the hair cells of the ear.

Sciele Pharma files NDA for glycopyrrolate oral solution

Sciele Pharma, Inc., a Shionogi company, today announced that it has submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for glycopyrrolate oral solution to treat chronic, moderate-to-severe drooling in pediatric patients. This condition often results from cerebral palsy as well as from other neurological disorders.

CSI's cancer cytogenetic testing receives COG approval

CSI Laboratories, a private national cancer diagnostics laboratory, has received approval from the Children's Oncology Group to begin analyzing pediatric cytogenetic cases. The Children's Oncology Group is the world's largest children's cancer research organization and includes more than 210 member hospitals with over 6,500 medical professionals.

Read more Medical News

› Verified 1 days ago